Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Altesa has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in February 2026.
Altesa's investors include Atlantic Partners, Sanofi, Pitango VC, Medicxi, Forbion Capital Partners.
Altesa is headquartered in College Park, United States.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Altesa is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altesa — Funding & Investors." VCBacked, February 19, 2026, https://www.vcbacked.co/company/altesa. Accessed August 16, 2026.
VCBacked. (2026). Altesa — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/altesa
{{cite web |title=Altesa — Funding & Investors |url=https://www.vcbacked.co/company/altesa |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated